In a study of prostate cancer patients from North Carolina, only 15% received monitoring as recommended by the NCCN.
In 2015, black men were 16% less likely than nonblack men to choose active surveillance or watchful waiting for low-risk prostate cancer.
In a study, just 12.1% of cases with focal positive surgical margins (PSM) experienced biochemical recurrence compared with 54.1% of those with extensive PSM.
Men treated with 5-alpha reductase inhibitors were diagnosed with prostate cancer 2 years later than men not using these drugs.
From 2010 to 2015, active surveillance/watchful waiting increased from 14.5% to 42.1%, according to a new study.
New study finds a prevalence of benign pathologic findings after PN of 30.9%.
Cytoreductive radical cystectomy may be beneficial for select patients with metastatic urothelial carcinoma of the bladder.
Despite research supporting nephrectomy as a treatment for metastatic renal cell carcinoma (mRCC), its use has not increased in 20 years.
The timing of adjuvant or salvage radiotherapy (RT) can affect erectile function recovery following radical prostatectomy (RP).
Greater percentages of patients with metastatic renal cell carcinoma (mRCC) are receiving treatment.
